SPINEMarketGroup

BRISBANE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the divestiture of iovera ®° to Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader. The iovera° system is an innovative, … [Read More...] about Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet

Author’s Note:Early-onset scoliosis (EOS) remains a complex condition, and research continues to explore more effective ways of managing it. With this article, my goal was to provide an overview of the different treatment strategies currently available, ranging from non-surgical approaches to advanced surgical systems. For those interested in specific devices, you can also explore the EOS Products … [Read More...] about Managing Early-Onset Scoliosis: Which Growth-Preserving Treatments Are Clinically Approved? Exploring Innovations and the Future of EOS Management.-Updated September 2025

Smart Scoliosis Developments is advancing a superelastic nitinol implant for adolescent idiopathic scoliosis. The concept is promising; the evidence, and two FDA-cleared rivals, are the catch. There is a stubborn gap in adolescent idiopathic scoliosis (AIS) that the industry has spent two decades trying to close: the space between the brace, which teenagers resist wearing, and spinal fusion, … [Read More...] about ProFlex Spine: Can a Nitinol Implant Crack Fusionless Scoliosis?

Spinal Alignment Solutions marks the first surgical case of its pelvic-incidence-based rod system. FORT WAYNE, IND. — June 9, 2026 — Spinal Alignment Solutions, Inc. (SAS) today announced the first-in-human implantation, worldwide, of its PI-Rod system, performed by spine surgeon Micah Smith, MD, in Fort Wayne, Indiana. PI-Rod is a system of pre-contoured spinal rods matched to a patient's … [Read More...] about First-in-Human Implantation of PI-Rod Performed Worldwide

Robotics in spine surgery is no longer just a topic for congress presentations, product launches or future-looking strategy decks. It is gradually entering hospitals, operating rooms and clinical routines. A recent example comes from Shore Medical Center in Somers Point, New Jersey, which has announced that it is now offering the VELYS™ Active Robotic Assistance Platform for spine surgery. … [Read More...] about J&J’s VELYS Spine Gains Traction with First New Jersey Installation at Shore Medical Center

In spine surgery, implant design is usually discussed in terms of fixation, fusion, subsidence, endplate contact and mechanical stability. These remain the core questions. But there is another issue that becomes very relevant after surgery: what happens when the patient needs a follow-up MRI? A recent peer-reviewed study published in Applied Sciences addresses this question directly. The … [Read More...] about Can the Design of a Spinal Cage Improve Tomorrow’s MRI?

MONTEREY, Calif.--(BUSINESS WIRE)--Elevation Spine announced today that its Saber-C Anterior Cervical Fusion System has surpassed 5,000 implantations, a milestone that reflects growing surgeon adoption of its proprietary integrated-fixation approach to anterior cervical discectomy and fusion (ACDF). The Saber-C system combines the stability of traditional anterior cervical plating with the … [Read More...] about Elevation Spine Surpasses 5,000 Saber-C® Implantations, Marking a Significant Milestone for Its Integrated Cervical Fixation Platform

BERN, SWITZERLAND, June 23, 2026 (Newswire.com) - LEM Surgical Inc., a pioneer in advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted an additional 510(k) clearance for its Dynamis Robotic Surgical System. This landmark milestone introduces further capabilities to the groundbreaking, surgical humanoid architecture that … [Read More...] about LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System

IMM Private Equity is reportedly close to acquiring a controlling stake in CGBio Co., the Korean regenerative medicine company affiliated with Daewoong Pharmaceutical, in a transaction that could value the deal at up to $730 million. According to Korean media reports, IMM PE may acquire as much as 80% of CGBio, following earlier reports that the firm had been selected as preferred bidder for a … [Read More...] about IMM PE Set to Acquire CGBio, Strengthening Korea’s Regenerative Spine Platform